Dimensional Fund Advisors LP raised its position in Analogic Corporation (NASDAQ:ALOG) by 9.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 767,558 shares of the medical research company’s stock after buying an additional 67,979 shares during the period. Dimensional Fund Advisors LP’s holdings in Analogic Corporation were worth $58,257,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Russell Investments Group Ltd. purchased a new stake in shares of Analogic Corporation during the fourth quarter valued at $3,637,000. State Street Corp raised its stake in shares of Analogic Corporation by 10.0% in the fourth quarter. State Street Corp now owns 319,302 shares of the medical research company’s stock valued at $26,482,000 after buying an additional 29,152 shares during the period. AQR Capital Management LLC raised its stake in shares of Analogic Corporation by 4.5% in the fourth quarter. AQR Capital Management LLC now owns 21,553 shares of the medical research company’s stock valued at $1,788,000 after buying an additional 923 shares during the period. Norges Bank bought a new stake in shares of Analogic Corporation during the fourth quarter valued at approximately $8,170,000. Finally, First National Bank of Omaha increased its stake in shares of Analogic Corporation by 18.6% in the first quarter. First National Bank of Omaha now owns 13,881 shares of the medical research company’s stock valued at $1,054,000 after buying an additional 2,174 shares in the last quarter.

Analogic Corporation (ALOG) traded up 1.58% during mid-day trading on Friday, hitting $70.70. The stock had a trading volume of 65,442 shares. The stock’s 50-day moving average is $70.44 and its 200 day moving average is $73.94. The company’s market capitalization is $881.63 million. Analogic Corporation has a 52 week low of $66.00 and a 52 week high of $95.85.

Analogic Corporation (NASDAQ:ALOG) last released its quarterly earnings data on Tuesday, June 6th. The medical research company reported $0.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.74 by $0.05. Analogic Corporation had a negative net margin of 7.97% and a positive return on equity of 6.75%. The firm had revenue of $122.16 million for the quarter, compared to analysts’ expectations of $121.35 million. During the same quarter in the previous year, the company earned $0.80 earnings per share. The company’s revenue for the quarter was down 4.5% compared to the same quarter last year. Equities analysts forecast that Analogic Corporation will post $2.62 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This report was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at https://www.thecerbatgem.com/2017/08/04/dimensional-fund-advisors-lp-boosts-position-in-analogic-corporation-alog-updated-updated-updated.html.

Analogic Corporation Company Profile

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Institutional Ownership by Quarter for Analogic Corporation (NASDAQ:ALOG)

Receive News & Stock Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related stocks with our FREE daily email newsletter.